Beverly Hills, CA, United States of America

Anat Ben-Shlomo

This inventor holds 1 USPTO granted patent. Top assignee: Cedars-Sinai Medical Center. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anat Ben-Shlomo. Retrieved from https://idiyas.com/inventor/anat-ben-shlomo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anat Ben-Shlomo: Innovator in Drug Screening Technology

Introduction

Anat Ben-Shlomo is a prominent inventor based in Beverly Hills, California. She has made significant contributions to the field of drug screening and characterization. Her innovative methods are aimed at improving the efficiency and accuracy of drug development processes.

Latest Patents

Anat holds a patent for a "Method for drug screening and characterization by calcium flux." This patent describes instrumentation and methods that utilize fluorescent ion imaging to record live cell responses to various drug doses. The technology allows for the computation of dose response curves and other pharmacological parameters by measuring oscillation changes in individual cells. This advancement provides a means of assessing statistical variability within cell populations, thereby enhancing drug screening and development methodologies.

Career Highlights

Anat is affiliated with Cedars-Sinai Medical Center, where she applies her expertise in drug screening technologies. Her work is pivotal in advancing the understanding of cellular responses to pharmacological agents.

Collaborations

Anat collaborates with esteemed colleagues, including Shlomo Melmed and Kolja Wawrowsky, to further her research and innovations in the medical field.

Conclusion

Anat Ben-Shlomo's contributions to drug screening technology exemplify her commitment to enhancing pharmaceutical development. Her innovative methods and collaborative efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…